Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Revue Des Maladies Respiratoires|January 26, 2023
[Face to a bilateral pneumothorax, just scratch your head!]S Valery, P Le Guen, E Guenzi, et al.
Molecular Microbiology|May 1, 1994
A two-component signal-transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniaeE Guenzi, A M Gasc, M A Sicard, et al.
The Journal of Biological Chemistry|November 26, 1998
Characterization of the syringomycin synthetase gene cluster. A link between prokaryotic and eukaryotic peptide synthetasesE Guenzi, G Galli, I Grgurina, et al.
The Journal of Biological Chemistry|June 11, 1998
Coordinate transcription and physical linkage of domains in surfactin synthetase are not essential for proper assembly and activity of the multienzyme complexE Guenzi, G Galli, I Grgurina, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 1, 1996
Resistance determinants for beta-lactam antibiotics in laboratory mutants of Streptococcus pneumoniae that are involved in genetic competenceD Zähner, T Grebe, E Guenzi, et al.
Nucleic Acids Research|July 11, 1992
A highly conserved repeated DNA element located in the chromosome of Streptococcus pneumoniaeB Martin, O Humbert, M Camara, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cellsD Rosa, S Campagnoli, C Moretto, et al.
The EMBO Journal|October 13, 2001
The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokinesE Guenzi, K Töpolt, E Cornali, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 14, 2026
Four-Year outcomes of first-line Nivolumab plus ipilimumab for 6 months versus continuation in patients with advanced non-small-cell lung cancer Results of the randomized IFCT-1701 "DICIPLE" Phase III trialG Zalcman, A Madroszyk, E Guenzi, et al.
Pageof 1